In addition, further investigation of the expression profiles of stem-cell markers, the c-kit pathway and its related molecules, and interactions with other tyrosine kinase signaling networks is required to clarify the reasons for the difference in the reported association between c-kit expression and OS of patients with SCLC. This evidence concerns the gene KIT and small cell lung carcinoma.